Title I — S. 5000 (Introduced in Senate)

Sec. 101 National Education Campaign

Section 102 of the Comprehensive Addiction and Recovery Act of 2016 (42 U.S.C. 290bb–25g) is amended—

(1)

in subsection (a), by inserting “or other controlled substances (as defined in section 102 of the Controlled Substances Act (21 U.S.C. 802))” after “opioids” each place such term appears;

(2)

in subsection (b), by striking “opioid” each place it appears and inserting “substance”;

(3)

in subsection (c)—

(A)

in paragraph (2), by striking “and” at the end;

(B)

in paragraph (3), by striking the period and inserting a semicolon; and

(C)

by adding at the end the following:

“(4) use destigmatizing language promoting humane and culturally competent (as defined in section 102 of the Developmental Disabilities Assistance and Bill of Rights Act of 2000 (42 U.S.C. 15002)) treatment of all individuals who face substance use disorder, including such individuals who use medication-assisted treatment for recovery purposes;

“(5) educate stakeholders on the evidence base and validation of harm reduction and where to obtain harm reduction services;

“(6) include information about polysubstance use; and

“(7) include information about prevention and treatment using medication-assisted treatment and recovery.”

(4)

by adding at the end the following:

“(d) Authorization of appropriations—There is authorized to be appropriated to carry out this section such sums as may be necessary for each of fiscal years 2021 through 2026.”

Sec. 102 Research into non-opioid pain management

(a)

In general— The Secretary of Health and Human Services, acting through the Director of the National Institutes of Health and the Director of the Centers for Disease Control and Prevention, shall carry out research with respect to non-opioid methods of pain management, including non-pharmaceutical remedies for pain and integrative medicine solutions.

(b)

Authorization of appropriations— To carry out this section, there are authorized to be appropriated such sums as may be necessary for each of fiscal years 2021 through 2026.

Sec. 103 Long-term treatment outcomes research

(a)

In general— The Secretary of Health and Human Services shall award grants to eligible entities to carry out evidence-based, long-term outcomes research, over 5-year periods, for different modalities of treatment for substance use disorder. Such research shall measure mortality, morbidity, physical and emotional health, employment, stable housing, criminal justice involvement, family relationships, and other quality-of-life measures. Such research shall distinguish outcomes based on race, gender, and socioeconomic status, as well as any other relevant characteristics.

(b)

Authorization of appropriations— To carry out this section, there are authorized to be appropriated such sums as may be necessary.

Sec. 104 National Commission for Excellence on Post-Overdose Response

(a)

In general— The Assistant Secretary of Health and Human Services for Mental Health and Substance Use (referred to in this section as the “Assistant Secretary”), in consultation with the Director of the Office of National Drug Control Policy, and the President of the National Academy of Medicine, shall establish an advisory commission, to be known as the “National Commission for Excellence on Post-Overdose Response”, that—

(1)

provides evidence, practical tools, and other resources for researchers and evaluators, clinicians and clinical teams, quality improvement experts, and healthcare decision makers to improve the quality and safety of care for drug overdoses and substance use disorder;

(2)

advises the individuals described in paragraph (1) on—

(A)

how to achieve equitable outcomes across race and socioeconomic status; and

(B)

how to effectively and appropriately control avoidable hospital admissions, emergency department admissions, and other adverse events related to substance use disorder care; and

(3)

develops culturally competent (as defined in section 102 of the Developmental Disabilities Assistance and Bill of Rights Act of 2000 (42 U.S.C. 15002)) best practices and clinical practice guidelines.

(b)

Membership— The members of the commission established under subsection (a) shall include—

(1)

a representative of the Substance Abuse and Mental Health Services Administration;

(2)

a representative of the Office of National Drug Control Policy;

(3)

a representative of the National Academy of Medicine;

(4)

a representative of the National Institute on Drug Abuse;

(5)

a substance use disorder specialist appointed by the Assistant Secretary;

(6)

a peer recovery specialist appointed by the Assistant Secretary; and

(7)

any other individual that the Assistant Secretary determines appropriate.

(c)

Sunset— The commission established under subsection (a) shall terminate on the date that is 10 years after the date of enactment of this Act.

Sec. 105 Workforce for prevention

Subpart 2 of part B of title V of the Public Health Service Act (42 U.S.C. 290bb–21 et seq.) is amended by adding at the end the following:

“519E. Employment and training services

“(a) In general—The Director of the Prevention Center shall—

“(1) not later than 30 days after the date of enactment of this Act, announce an opportunity to apply for grants or contracts awarded to support the activities described in subsection (b); and

“(2) from the funds appropriated under subsection (c), not later than 45 days after the date on which an entity submits an application that meets the requirements of the Secretary under this section, award funds under this section to such entity.

“(b) Use of funds—An entity that receives funds under this section shall use the funds to support employment and training services for substance use treatment professionals, including peer recovery specialists.

“(c) Authorization of appropriations—There are authorized to be appropriated to carry out this section such sums as may be necessary for each of fiscal years 2021 through 2026.”

Sec. 106 Reauthorization of community-based coalition enhancement grants to address local drug crises

Section 103(i) of the Comprehensive Addiction and Recovery Act of 2016 (21 U.S.C. 1536(i)) is amended by striking “there are authorized to be appropriated $5,000,000 for each of fiscal years 2017 through 2021.” and inserting the following:

“(1) $5,000,000 for each of fiscal years 2017 through 2020; and

“(2) $10,000,000 for each of fiscal years 2021 through 2026.”

Title I — Research, education, and prevention

I Research, education, and prevention